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1. Introduction 
Dental caries is the most prevalent oral disease that affects a significant part of the world 
population, especially in less developed countries. It is universally accepted that the dental 
caries is a chronic and multifactorial disease [1-3]. The permanence of the bacterial plaque on 
the tooth surface will lead to loss of minerals constituents of the dental enamel promoting the 
installation of the carie disease. The carious lesion is characterized by the tooth structure 
(hydroxyapatite) demineralization by the production of organic acids, such as lactic acid, 
resulting from bacterial (dental biofilm) metabolism. This results in loss of calcium and 
phosphate ions which subsequently diffuse out of the tooth. In this complex process, the 
microorganisms, particularly Streptococcus species, have an important role in its etiology [3-5]. 
Many oral Streptococcus in the presence of carbohydrate produce organics acids and 
insoluble glucans which serve as binding sites for bacteria on the tooth surface, forming the 
biofilm. The sucrose plays an important role in carie development, influencing on biofilm 
acidogenicity and cariogenic microflora. The high cariogenicity of dental plaque formed in 
the presence of sucrose can be mainly explained by the high concentration of insoluble 
glucans on its matrix, the low inorganic concentration and its protein composition may have 
some contribution [6, 7].  
Specifics microorganisms are associated with dental plaque formation, development and 
maturation. The Streptococcus mutans is a member of the oral microbial community which 
plays a key role in formation of cariogenic biofilms. The key factors of S. mutans cariogenic 
are the production of a great variety of carbohydrates, which generate low pH and cause the 
consequent demineralization of the tooth enamel [3, 8-10]. 
 
Practical Applications in Biomedical Engineering 230 
Recent developments in the areas of biomaterials devices have resulted in a number of 
advances in the searches of natural substances which may inhibit the dental plaque 
formation and/or the hydroxyapatite demineralization [11, 12]. In particular, this research is 
focused on novel macromolecules and biocompatible materials for use in clinical 
applications. Chitosan is a non-toxic and natural polysaccharide, which have many 
biological applications, mainly as antimicrobial agent [12].  
2. Chitosan: General considerations 
Chitosan is a natural co-polymers of chitin, composed by units of 2-amino-2-desoxi-D-
glycopyranose and of 2-acetamide-2-desoxi-D-glycopyranose interconnected by glycosidic 
bonds β-1,4 in variable proportions. The first type of units is frequently present in chitosan. 
This polymer is naturally found in the cell wall of fungi, mainly in the Mucorales order [5, 
13, 14]. Chitosan is formed by the chitin deacetylation, and the group N-acetyl can be suffer 
several degrees of deacetylation (Figure 1). Chitosan is characterized according to its 
deacetylation level and molar mass, once such features may influence the degradability and 
in the polysaccharide hydrolysis [15, 16]. According to the medium acetylation level (AL), 
chitosan may be obtained with physical-chemical properties differentiated regarding the 
solubility parameters, pKa and viscosity [17, 19]. It is difficult to obtain chitosan with high 
deacetylation level as due long process of isolation, and the degradation of the polymer also 
increases [5, 15]. 
 
 
Figure 1. Chemical structure of Chitin and Chitosan (Source: authors) 
The synthesis of chitin from fungi and crustaceans differs significantly; however, steps of 
enzymatic machinery for biosynthesis and catalytic regulation are similar. In crustaceans is 
initiated by conversion of glucose 6-phosphate N-acetylglucosamine-1-phosphate, involving 
a series of stages that require several enzymatic reactions. N-acetylglucosamine-1-phosphate 
reacts with UTP forming the UDP N-acetylglucosamine, which finally transfers N-
acetylglucosamine for the polymerization of chitin chains in a process mediated by the 
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enzyme chitin synthase and Mg +2 ion as catalyst, resulting in the formation of a long chain 
of subunits monosaccharide’s linked by β-1 → 4. Chitosan is thus obtained by deacetylation 
of chitin by chemical treatment with NaOH at high temperature [20].  
Fungi the chitin and chitosan synthesis simultaneously were occurred. The synthesis of 
chitin is highly compartmentalized. The enzyme chitin synthase is the zymogen form and 
distributed in specific regions of the cell surface, vesicles in specialized, chitosome. The 
macromolecular assembly starts out of the cytoplasm, where the protease enzyme acts on 
the cell surface activating the zymogenes. In this way the UDP N-acetylglucosamine is 
produced from glucose, and chitin synthase catalyzes the transfer of N-acetylglucosamine 
for polymerization chain forming chitin. The chitosan present in cell walls of certain fungi 
(Mucorales) is formed from the deacetylation (chitin deacetylase) chain chitin source for the 
biosynthesis of chitin. The regulations of the synthesis of chitin and chitosan are determined 
by the spatial organization of the synthesis of chitin in the cell surface [20, 21]. 
Crustacean chitosan is inconsistent in its physical–-chemical properties due to the variability 
in raw materials, the harshness of the isolation and conversion processes, the caustic effects 
of the chemicals used in the isolation process, and variability in the levels of deacetylation 
and protein contamination [22-24]. 
The use of biomass from fungi have demonstrated a great advantages, such as: 
independence of seasonal factor, wide scale production, simultaneous extraction of chitin 
and chitosan, extraction process is simple and cheap resulting in reduction of the time and 
cost required for production, and also absence of proteins contamination, mainly the 
proteins that could cause allergy reactions in individuals with shellfish allergies. However, 
to optimize the production of chitin and chitosan from fungi, it's usually used complex or 
synthetics cultures media, which are expensive. It’s becomes necessary to obtain economic 
culture media that promote the growth of fungi and stimulate the production of the 
polymers [25-32].  
In order to obtain alternative sources of nutrients and low cost several research projects are 
being conducted. Table 1 shows the use of various synthetic media and low cost alternative 
media used for growth of fungi of the order Mucorales, and production of chitin and 
chitosan. The content of chitin and chitosan from fungal cell wall varies among different 
species and growth conditions. Many studies have been performed to verify the possibility 
of using the biomass of fungi, especially Mucorales, class Zygomycetes, as an alternative 
source of chitin and chitosan. Many of these studies test simple models to verify the 
production of chitin and chitosan, ie, the approach adopted experiments using only one 
variable at a time during the fermentation, eg after cultivation, agitation, pH, temperature 
and concentration of nutrients. However, the literature report in recent years the scientific 
interest to reduce the numbers of tests and increase the accuracy of the results has been 
increased. Therefore, multivariate approach, using factorial design, allows the observation 
of the synergistic effect between the independent variables, since all variables are 
considered simultaneously, resulting in the final optimize conditions [30-34]. 
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Microorganism Substrate Biomass
(g.L-1) 
Chitin
(mg.g-1) 
Chitosan 
(mg.g-1) 
Reference 
Mucor circinelloides Yam bean 20.70 500 64 33 
Cunninghamella elegans Yam bean 24.30 440 66 32 
Cunninghamella elegans Hesseltine and 
Anderson added 
of 5%NaCl and 
6%glucose
24.40 388 70 29 
Cunninghamella 
bertholletiae 
Sugar cane juice 7.70 - 128 30 
Aspergillus niger Potato Dextrose 
Broth  
9.00 - 107 34 
Lentinus edodes Potato Dextrose 
Broth 
1.4 - 33 34 
Zygosaccharomyces rouxii Yeast Malt 
Extract Broth 
4.4 - 36 34 
Candida albicans Yeast Malt 
Extract Broth 
1.8 - 44 34 
Rhizomucor miehei Sabouraod 
dextrose (SDB) 
4.1 - 13.67 24 
- Data not shown 
Table 1. Chitin and chitosan production by Mucorales strains compared with Cunninghamella 
cirnelloides using yam bean as substrate. 
3. Properties, antimicrobial and toxicity of fungi chitosan  
Chitosan has numerous applications in several areas, mainly biomedical and pharmaceutical 
fields, due to its specific properties Among their properties we highlight the excellent 
biocompatibility; almost any toxicity to human beings and animals; high bioactivity; 
biodegradability; reactivity of the group amino deacetylated; selective permeability; 
polyelectrolyte action; antimicrobial activity; ability to form gel and film; chelation ability and 
absorptive capacity [36-38]. These peculiar properties provide a variety of applications to the 
chitosan, such as: drug carrier of controlled release [36], anti-bacterial [37, 39] and anti-acid 
[38]; inhibition of the bacterial plaque formation and decalcification of dental enamel [2, 10]; 
promotes the osteogenesis [40]; and promotes the healing of ulcers and lesions [41, 42].  
The applicability of chitosan is related to their physical-chemical properties considering the 
different sources (crustaceans, fungi, and mollusk’s) and different processes for extraction 
and purification cause alterations in the degree of deacetylation, molecular weight, thermal 
stability and degree of crystallinity of the chitosan. Various derivatives of chitosan differ of 
the degree of deacetylation, molar weight, arrangement of residual N-acetyl groups in the 
chain considering the reaction of -NH 2 group at the carbon 2 (C2) or unspecific -OH group 
in position 3 carbons or 6 (C3 or C6) of the polymer with other functional groups are 
reported in the literature [15].  
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Chitosan is a weak base insoluble in water but soluble in dilute aqueous solutions of various 
acids, the most widely used is acetic acid [43]. The acid solubility is explained by the 
protonation of the free amino group, characteristic in the chitosan in natura, which change to 
NH2 to NH3+, whereas in alkaline condition, the hydro solubility is due to the formation of 
carboxylate, from the introduced carboxylic group [19, 44]. The possibility to obtain a 
variety of polymer derivatives with differences solubility, thermal stability, reactivity with 
other substances and specificity regarding the binding site, providing several biological 
applications of the chitosan [15]. Some applications of the chitosan, it is highligh it’s the use 
in the pharmaceutical industry, more specifically related to dental clinic [43]. 
Chitosan has a recognized antimicrobial activity, being this, one of the main properties of 
the polysaccharide. Several researchers demonstrated that this polysaccharide has 
antimicrobial action in a great variety of microorganisms, included gram-positive bacteria 
and various species of yeast [21, 45]. In the literature is described that chitosan acts in the 
cellular wall of the microorganism modifying the electric potential of the cellular membrane 
[46]. This polysaccharide also acts potentiating other inhibition drugs, as the chlorhexidine 
gel, once it increases the drug permanence time action place [47, 48]. 
In reference [39] the authors report that chitosan has demonstrated low toxicity and the 
resistance development have not occurred. The antimicrobial action of the chitosan and its 
derivatives suffers influence from factors, which depending on the performed role may be 
classified in four main categories: 1. Microbial factors as species, age of the cell); 2. Intrinsic 
factors of the chitosan as: positive charge density, molecular weight, hydrophobic and 
hydrophilic characteristics, chelation capacity; 3. Physical state factors (soluble and solid 
state), and 4. Environmental factors (pH, ionic forces, temperature, and time). 
The antimicrobial action mechanism of the chitosan is not yet fully elucidated, being several 
mechanisms are suggested by the literature. Some authors suggested the amino groups of 
the chitosan when in contact with physiological fluids are protonated and bind to anionic 
groups of the microorganisms, resulting in the agglutination of the microbial cells, and 
growth inhibition [49, 50]. On the other hand, reference [49] report that when interacting 
with the bacterial cell, the chitosan, promotes displacement of Ca++ of the anionic sites of the 
membrane, damaging them. Another postulate is the interaction between the positive load 
of the chitosan and the negative load of the microbial cell wall, because it causes the rupture 
and loss of important intracellular constituent of the microorganism life. Chitosan with low 
molecular weight penetrates in the cell and is linked to the microorganism DNA inhibiting 
the transcription and consequently the translation, whereas the chitosan of high molecular 
weight acts as a chelate agent, binding to the cell membrane [16]. 
Authors in reference [47] investigated the relation between antimicrobial activity of the 
chitosan and the characteristics of the cellular wall of bacteria. They verified that the 
chitosan is antibacterial agent more efficient to Gram-negative bacteria due the composition 
of phospholipids and carboxylic acids of the bacterial cellular wall. These results suggest 
that the effects of the chitosan are distinct in the two types of bacteria: in the case of the 
gram-positive, the hypothesis is that chitosan of high molecular mass may form films 
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around the cell that inhibit the absorption of nutrients, while chitosan of low molecular 
mass penetrates more easily in gram-negative bacteria, causing riots in the metabolism of 
these microorganisms.  
Chitosan from M. circineloides was obtained as described the literature [33]. The chitosan 
with different molecular weight was obtained by methods of extraction. Hight molecular 
weight of chitosan was obtained by methodology described by Stamford et al [32], and Fai et 
al.[ 33], and low molecular weight of chitosan by methodology described by Hu et al.[54]. 
The degree of deacetylation for chitosan was determined by infrared spectroscopy, the 
molecular weights by viscosity described by Stamford et al [32] and Fai et al.[33]. However, 
the chitosan with low molecular weight showed antimicrobial activity to Gram positive and 
negative bacteria than chitosan of high molecular weight (Table 2) 
 
Bacteria Minimum inhibitory concentration
(mg/ml) 
Minimum bactericidal 
concentration (mg/mL) 
Chitosan Chitosan 
ChLMW ChHMW ChLMW ChHMW 
S. aureus 1.25 2.5 2.5 5.0 
E. coli 1.25 2.5 2.5 5.0 
P. aeroginosa 0.625 1.25 1.5 5.0 
S. mutans 0.625 1.25 1.5 5.0 
Table 2. Minimum Inhibitory Concentration (mg.mL-1) of chitosan from Mucor circineloides with 
different molecular weight: Low molecular weight chitosan with 3.2 x 103 g/mol (ChLMW) and higher 
molecular weight chitosan 2.72 x 105 g/mol (ChHMW),  against pathogenic bacteria 
Studies in vitro were carried out in the Microbiology laboratory of UFPB to determine the 
Minimum Inhibitory Concentration (CIM) and the Minimum Bactericidal Concentration 
(MBC) of chitosan from different origins, and varying the parameters deacetylation degree 
and molecular weight to oral Streptococcus species. The results showed greater influence of 
the molecular weight of the polymer on antibacterial activity. The low molecular weight of 
chitosan have shown higher antimicrobial activity to CIM and CBM, when compared with 
chitosan gel (soluble in acetic acid 1%), and with higher molecular weight, as described in 
the Table 3. 
In addition, chick embryo chorioallantoic membrane (CAM), is a rapid and inexpensive 
method for determination of tissue reactions to biomaterials, and was used to evaluate the 
chitosan toxicity and physiological compatibility. Positive control was used as sodium lauryl 
sulfate 1%. The method allows prediction of the potential irritation by chitosan was studied. 
Fertile hen’s eggs at 10º days of incubation at 37°C, obtained from Guaraves Guarabira Aves 
Ltda, were used in the tests. Five eggs were used for each chitosan solution assayed. On day 
10 of incubation, the egg shell above the air space was removed. The exposed membrane 
was moistened with a drop of 0.9% physiological saline and the saline was removed, 
uncovering the CAM. An aliquot of 200 µl of chitosan solution was applied on the CAM. 
Signs of vasoconstriction, hemorrhage and coagulation for 5 minutes were observed to 
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evaluate the potential for irritation according to the method of HET-CAM. Thus, 
biocompatibility of chitosan was evaluated including the search for signs of inflammation, 
edema or neovascularization [55].  
 
Chitosan Streptococcus species 
 
S. mutans S. sanguis S. oralis S. mitis 
CIM CBM CIM CBM CIM CBM CIM CBM 
Crustaceans 65DA%  
3,5 x 106 
1.25 5.0 1.25 7.5 1.25 5.0 1.25 5.0 
Crustaceaus 
90DA% 3,5 x 106 
1.25 2.5 1.25 5.0 1.25 2.5 1.25 2.5 
Crustaceans 
90DA% 3,1 x 104 
0.625 1.25 0.625 2.5 0.625 1.25 0.625 1.25 
Fungi 
80% DA 2,72x 106 
1.25 2.5 1.25 2.5 1.25 2.5 1.25 2.5 
Fungi 
90% DA 2,72x 106 
1.25 2.5 1.25 2.5 1.25 2.5 1.25 2.5 
Fungi 
90% DA 2,3x 104 
0.625 1.25 0.625 1.25 0.625 1.25 0.625 1.25 
Table 3. Studies in vitro performed by Microbiology laboratory, UFPB (João Pessoa-PB, Brasil) 
demonstrating the Minimum Inhibitory Concentration (CIM) and Minimum Bactericidal Concentration 
(CBM) of the chitosan (derivatives from different origins, 80 and 90% of deacetylation degree (DA), 
molecular weight (MW) g/mL and solubility) to Streptococcus species 
 
Assays Chmw Clmw SLS 1% 
Vasoconstriction 0.0±0.0 0.0±0.0 6.0 ±1.0 
Hemorrhage 0.0±0.0 0.0±0.0 48 ±3.0 
Coagulation 0.0±0.0 0.0±0.0 63 ±3.0 
Irritation potential 0.0±0.0 0.0±0.0 17,74 ± 0,4 
Non-irritating: 0-0.9 ; slightly irritating: 1-4.9; Irritating: 5-8.9 and  Severely irritating: 9-21 
Table 4. Test of chitosan to high (Chmw) and low (Clmw) molecular weight against vasoconstriction, 
hemorrhage and coagulation. Positive control: sodium lauryl sulfate 1% (SLS1%). 
 
Assays 
Inflammation edema neovascularization 
Chmw Clmw Chmw Clmw Chmw Clmw 
1 0.0 0.0 0.0 0.0 0.0 0.0 
2 0.0 0.0 0.0 0.0 0.0 0.0 
3 0.0 0.0 0.0 0.0 0.0 0.0 
4 0.0 0.0 0.0 0.0 0.0 0.0 
5 0.0 0.0 0.0 0.0 0.0 0.0 
Table 5. Test of chitosan to high (ChHMW) and low (ChLMW) molecular weight for inflammation, 
edema and neovascularization. 
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4. Anticariogenic effects of chitosan 
Experiments were performed in the Microbiology Laboratory-Nucleus of Research in 
Environmental Sciences- UNICAP (Recife, PE, Brazil) regarding the safety concentration for 
the dilution of fungi chitosan in acetic acid. The mechanisms of chitosan from crabs and 
fungi to inhibit the tooth colonization by S. mutans, S. sanguis, S. mitis and S. oralis were 
evaluated through the adherence test of chitosan to dental and bacteria surface, results 
showed in Figure 2. Chitosan from crabs and fungi, in all concentration tested, decreased the 
adsorption of Streptococcus strains to dental enamel, reduced the bacteria cell wall 
hydrophobicity and decreased the glucan production by bacteria. However, chitosan from 
fungi was more efficient than chitosan from crabs for the tree parameters studied. 
Figure 2A shows the decrease of bacteria adsorption to dental enamel in the presence of 
chitosan from crabs and fungi, in all concentrations studied. Chitosan demonstrated best 
performance at the concentration of 2mg/mL for S. mutans and of 3mg/mL for S. sanguis, S. 
mitis and S. oralis. These results are in agreement with the one obtained by [8], which 
studied the effect of chitosan from crabs of low molecular weight in the adsorption of S. 
mutans, S. sanguis and S. oralis to the commercial hydroxyapatite. 
Researchers [9, 10] investigated, “in vivo”, the activity of a chitosan mouthrinse, respectively 
of 1% and 0.5%, and verified significant reduction of dental plaque formation. The authors 
reported that chitosan might be altering of the electrostatic interaction between the bacterial 
cell surface in saliva and tooth pellicle surface. The electrostatic interaction is usually 
repulsive due to the fact that inature both bacteria and the pellicle surface are 
predominantly negatively charged. The chitosan chains attach themselves to the negatively 
charged bacterial cell surface by means of their positively charged groups. If these chains are 
of a sufficient length to bind more than one cell, bridges are formed between bacterial cells. 
As soon as the bridging becomes effectives flocs are formed, and the bacteria cannot 
colonize the tooth surface.  
In literature [8-10] is reported that aggregating oral bacteria may reduce their adherence to 
tooth surface. The polycationic nature of chitosan might reduce the initial bacterial 
adherence onto the teeth surfaces, at least in part, by generating bacterial aggregation. There 
have also been suggestions that bacterial aggregates are removed more easily from the oral 
cavity than individual bacterial cells.  
To verified the influence of chitosan, sublethal concentration, to modification in bacterial cell 
surface, it was evaluated the affinity of chitosan to xylene of bacteria grown in the presence 
or absence of chitosan sub-MICs, through hydrophobicity tests (Figure 2B), and for sucrose 
catabolization, through extracellular glucan production by bacteria strains (Figure 2C). The 
results in figure 2B indicates that increasing concentration of chitosan in bacterial 
suspension caused a successive decrease of the bacteria cell wall hydrophobicity, being 
more evident for the S. mutans strain. These results are supported by findings of [8,9]. These 
authors suggested that chitosan induced a successive decrease in cell hydrophobicity, and 
that surface hydrophobicity is related to adherence ability of bacteria. Therefore, the 
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inhibiting effects of chitosan may depend, at least, partially, on alterations of bacterial cell 
surface hydrophobicity expression.  
In figure 2C is observed a decreasing of extracellular glucan production by bacteria strain in 
presence of sucrose, with increasing chitosan concentration. The ionic interaction between 
the cation, according to [61,62], from chitosan (amine group) and anionics parts of bacteria 
cell wall (phospholipids and carboxylic acids) can form a membrane polymer, which 
prevents nutrients from entering the cell. Since chitosan could adsorb the electronegative 
substance, this polymer can promote cell flocculate, and disturbs the physiological activities 
of the bacteria and kill them. Authors [63] reported that chitosan interact with the 
electronegative bacterial cell surface resulting in displacement of Ca++ from anionic 
membrane sites, resulting in a changing the electric potential of the bacteria surface. 
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C 
Figure 2. Diagram of stratification dispersion of chitosan from fungi and crabs activity: inhibition of 
bacteria adsorption on dental enamel (A); hydrophobicity of bacteria surface (B) and glucan production 
by bacteria (C). 
Experiments were conducted in the department of chemistry's fundamental UFPE verified the 
penetration depth of chitosan in teeth enamel for two specimens by Optical Coherence 
Tomography (OCT) images. Chitosan was applied only to half of the teeth surface. The image 
in the left was obtained for a chitosan concentration of 1.25mg/ml. it is clearly seen the 
penetration of chitosan as indicated by the brighter area (caused by light scattering) in the 
figure, only in the region where chitosan may act as a mechanical barrier for the acid 
penetration in the enamel, which would explain its effect in the demineralization inhibition [2]. 
 
Sources: [2] 
Figure 3. Optical Coherence Tomography (OCT) images of specimens treated with chitosan at 
1.25mg/mL (left) and 5.0mg/mL (right)  
6. Conclusion 
The use of chitosan in different formulations, such as toothpaste (Chitodent®), mouthwash 
solution and chewing gum, is mentioned in literature [8-10]. In all forms the chitosan has 
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shown antibacterial action for bacteria belonging to the group Streptococcus, inhibits the 
growth and adherence of cariogenic bacteria and the desmineralization process of dental 
enamel in vitro, and stimulates salivation, in vivo. The results confirm a high 
biotechnological potential for chitosan from both fungi and crab sources as a cariostatic and 
anticariogenic agent, suggesting their application as dentistry biomaterial for prevention 
and therapeutic of dental carie. 
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